Item Details

Print View

Hearing on Food and Drug Administration Activities [electronic resource]

United States. Congress. House. Committee on Government Operations; United States Congress House Committee on Government Operations Intergovernmental Relations Subcommittee
Format
Online; EBook; Government Document
Published
[S.l] : [s.n.], 1970.
Language
English
Series
ProQuest U.S. Congressional Hearings Digital Collection
Summary
Continuation of hearings to review FDA regulatory policies. Examines regulation of oral contraceptives, particularly the new drug Demulen, FDA drug approval process and labeling regulations, and research on possible health risks of oral contraceptives containing high dosages of estrogen.
Description
102 p.
System requirements: PDF reader software.
Notes
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
  • Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
  • CIS No. HRG-1970-OPH-0037
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection(last viewed Nov. 2009). Reuse except for individual research requires license from ProQuest, LLC.
Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Staff View

    LEADER 02068nam a22002891a 4500
    001 cis2007526283
    006 m d f
    007 cr bn mmmapmmp
    008 091130s1970 dcu s f000 0 eng d
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Government Operations.
    245
    1
    0
    a| Hearing on Food and Drug Administration Activities h| [electronic resource]
    260
      
      
    a| [S.l] : b| [s.n.], c| 1970.
    300
      
      
    a| 102 p.
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
    500
      
      
    a| Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
    500
      
      
    a| CIS No. HRG-1970-OPH-0037
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection(last viewed Nov. 2009). Reuse except for individual research requires license from ProQuest, LLC.
    520
      
      
    a| Continuation of hearings to review FDA regulatory policies. Examines regulation of oral contraceptives, particularly the new drug Demulen, FDA drug approval process and labeling regulations, and research on possible health risks of oral contraceptives containing high dosages of estrogen.
    538
      
      
    a| System requirements: PDF reader software.
    650
      
    0
    a| Contraceptives.
    650
      
    0
    a| Drugs.
    650
      
    0
    a| Estrogen.
    710
    1
      
    a| United States. b| Congress. b| House. b| Committee on Government Operations. b| Intergovernmental Relations Subcommittee.
    776
    0
    8
    a| United States. Congress. House. Committee on Government Operations. t| Hearing on Food and Drug Administration Activities. o| 91 HGov-T.10
    830
      
    0
    a| ProQuest U.S. Congressional Hearings Digital Collection.
    856
    4
    0
    u| http://proxy.its.virginia.edu/login?url=http://congressional.proquest.com/congcomp/getdoc?HEARING-ID=HRG-1970-OPH-0037 y| Electronic resource (PDF)
    040
      
      
    a| UMI c| UMI
▾See more
▴See less

Availability

Read Online